LEADER 03385nam  2200589   450 
001 9910811811003321
005 20230316164438.0
010   $a2-7420-0870-5
035   $a(CKB)3710000000088058
035   $a(EBL)3317960
035   $a(SSID)ssj0001128733
035   $a(PQKBManifestationID)12442570
035   $a(PQKBTitleCode)TC0001128733
035   $a(PQKBWorkID)11075468
035   $a(PQKB)10071951
035   $a(MiAaPQ)EBC3317960
035   $a(Au-PeEL)EBL3317960
035   $a(CaPaEBR)ebr10836906
035   $a(OCoLC)874162693
035   $a(PPN)198673272
035   $a(EXLCZ)993710000000088058
100   $a20140217h20062006  uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aNeurocutaneous syndromes in children /$feditors, P. Curatolo, D. Riva
210  1$aMontrouge :$cJohn Libbey Eurotext,$d[2006]
210  4$dİ2006
215   $a1 online resource (247 pages) $cillustrations (some color)
225  0$aMariani Foundation paediatric neurology series,$x0969-0301 ;$v15
300   $aDescription based upon print version of record.
311 0 $a2-7420-0609-5 
320   $aIncludes bibliographical references.
327   $a""NEUROCUTANEOUS SYNDROMES IN CHILDREN""; ""Contents""; ""Chapter 1 - Embryological basis of the neurocutaneous syndromes""; ""Chapter 2 - Neurocutaneous diseases in children and adolescents: general clinical pattern""; ""Chapter 3 - Hypomelanosis of Ito""; ""Chapter 4 - Vascular malformations and neurocutaneous disorders""; ""Chapter 5 - Neurocutaneous syndromes and hemimegalencephaly""; ""Chapter 6 - Two rare neurocutaneous syndromes: Wyburn-Mason and Proteus""; ""Chapter 7 - Diagnostic criteria and evaluation of patients with tuberous sclerosis complex""
327   $a""Chapter 8 - Epileptic manifestations in tuberous sclerosis"" ""Chapter 9 - Tuberous sclerosis complex: phenotype-genotype correlations""; ""Chapter 10 - Subependymal giant cell astrocytomas and tuberous sclerosis""; ""Chapter 11 - Neurosurgical strategies in the management of subependymal giant cell tumoursin tuberous sclerosis complex""; ""Chapter 12 - The neurofibromatoses: clinical manifestations, natural history and management""; ""Chapter 13 - Neurofibromatosis type 1: the dermatological option""; ""Chapter 14 - Clinical molecular genetics of the neurofibromatoses""
327   $a""Chapter 15 - Cognitive-behavioural phenotype and neurobiological basis of neurofibromatosis type 1""""Chapter 16 - Brain tumours in neurofibromatosis type 1""; ""Chapter 17 - Novel therapeutic approaches for plexiform neurofibromas in neurofibromatosis type 1""; ""Chapter 18 - Adjuvant therapy for low-grade glioma in neurofibromatosis type 1""; ""Chapter 19 - Diagnostic and follow-up protocols for neurofibromatosis types 1 and 2""
410  0$aMariani Foundation paediatric neurology series  ;$v15
606   $aNeurocutaneous disorders
606   $aSkin$xDiseases
615  0$aNeurocutaneous disorders.
615  0$aSkin$xDiseases.
701   $aRiva$b Daria$01674248
701   $aCuratolo$b Paolo$0140447
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910811811003321
996   $aNeurocutaneous syndromes in children$94038912
997   $aUNINA